Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders

Details for Australian Patent Application No. 2010258223 (hide)

Owner SEPAL PHARMA LTD.

Inventors Herzberg, Max; Raveh, Frederic

Agent Pipers

Pub. Number AU-A-2010258223

PCT Pub. Number WO2010/143180

Priority 61/185,221 09.06.09 US; 61/249,265 07.10.09 US

Filing date 3 June 2010

Wipo publication date 16 December 2010

International Classifications

C12P 7/40 (2006.01) Preparation of oxygen-containing organic compounds - containing a carboxyl group

Event Publications

12 January 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Herzberg, Max and Revah, Frederic

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/143180 Priority application(s): WO2010/143180

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258226-Stabilized and activated bromine solutions as a biocide and as an antifouling agent

2010258222-Air vehicle